Article ID Journal Published Year Pages File Type
3440316 American Journal of Obstetrics and Gynecology 2007 10 Pages PDF
Abstract
These studies provide critical insights regarding Ad5-Δ24-RGD dosing and anticipated toxicity for a planned clinical trial for ovarian cancer.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Medicine and Dentistry (General)
Preview
Identifying the safety profile of a novel infectivity-enhanced conditionally replicative adenovirus, Ad5-Δ24-RGD, in anticipation of a phase I trial for recurrent ovarian cancer
Authors
, , , , , , , , , , , , , , ,